CLGN logo
CLGN NASDAQ IL

CollPlant Biotechnologies Ltd. - Ordinary Shares

Healthcare · Biotechnology Website · IPO Sep 1993
$0.53
▼ $-0.01 (-0.94%)
Vol 88K
4
Quality Score
fail
Mkt Cap
$17.8M
ROE
-102.0%
Margin
-491.3%
D/E
0.00
Beta
0.76
52W
$1–$5

Wall Street Consensus

8 analysts · Apr 2026
2
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
75.0%
Buy Rating

Price Chart

Similar Stocks

PLRZ
Polyrizon Ltd
$13.5M
CMMB
Chemomab Therapeutics Ltd
$10.1M
QNRX
Quoin Pharmaceuticals Ltd
$8.5M
EVGN
Evogene Ltd
$9.6M
SLXN
Silexion Therapeutics Corp
$6.0M
GLMD
Galmed Pharmaceuticals Ltd
$4.1M
URGN
Urogen Pharma Ltd
$1.1B

Earnings

Beat rate: 0.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.19 $-0.26 $-0.07
Sep 2025 $0.16 $-0.27 $-0.43
Jun 2025 $-0.14 $-0.28 $-0.14
Mar 2025 $-0.04 $-0.13 $-0.09

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -94.1% -87.3% -94.1% -94.1% -94.1% -102.0%
P/E (TTM) — — — — — —
Net Margin -1869.8% -560.9% -541.3% -541.3% -541.3% -491.3%
Gross Margin -3.9% 48.7% 61.8% 61.8% 61.8% 63.0%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 4.60 4.48 4.60 4.60 4.60 3.66

Key Ratios

ROA (TTM)
-72.1%
P/S (TTM)
7.19
P/B
3.1
EPS (TTM)
$-1.02
CF/Share
$-0.50
Rev Growth 3Y
-68.0%
52W High
$4.98
52W Low
$1.30
$1.30 52-Week Range $4.98

How does CLGN compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

CLGN AAPG ABEO ABOS ABP

CLGN valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
7.2
▼ 44% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
3.1
▲ 24% above peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

CLGN profitability vs Biotechnology peers

ROE
-102.0%
▼ 52% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-491.3%
▼ 71% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
63.0%
▼ 20% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-72.1%
▼ 54% below peers (-46.7%)
vs Peers
vs Industry
Weak

CLGN financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.7
▼ 18% below peers (4.4)
vs Peers
vs Industry
Below avg
Beta
0.8
▼ 22% below peers (1.0)
vs Peers
vs Industry
More volatile

CLGN fundamentals radar

CLGN Peer median Industry

CLGN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

CLGN vs peers: key metrics

Latest News

No related news yet